Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing whether colchicine can prevent recurrence of lobar intracerebral hemorrhage in patients with cerebral amyloid angiopathy; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Huashan Hospital | Conditions: Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar | Phase 2 | Status: RECRUITING